100
Participants
Start Date
September 1, 2022
Primary Completion Date
December 31, 2032
Study Completion Date
December 31, 2032
no intervention
No intervention. Observational study only
Oslo University Hospital, Oslo
Norwegian Institute of Public Health
OTHER_GOV
Norwegian Medicines Agency
OTHER_GOV
Oslo University Hospital
OTHER